Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007

M MacManus, U Nestle, KE Rosenzweig… - Radiotherapy and …, 2009 - Elsevier
Positron Emission Tomography (PET) is a significant advance in cancer imaging with great
potential for optimizing radiation therapy (RT) treatment planning and thereby improving …

European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer

D De Ruysscher, C Faivre-Finn, U Nestle… - Journal of clinical …, 2010 - ascopubs.org
Purpose To derive recommendations for routine practice and clinical trials for techniques
used in high-dose, high-precision thoracic radiotherapy for lung cancer. Methods A literature …

Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes …

U Nestle, S Kremp, AL Grosu - Radiotherapy and oncology, 2006 - Elsevier
The value of positron emission tomography using [ 18 F]-fluoro-deoxy-glucose (FDG-PET)
for pretherapeutic evaluation of patients with non-small cell lung cancer (NSCLC) is beyond …

Comparison of different methods for delineation of 18F-FDG PET–positive tissue for target volume definition in radiotherapy of patients with non–small cell lung cancer

U Nestle, S Kremp, A Schaefer-Schuler… - Journal of nuclear …, 2005 - Soc Nuclear Med
PET with 18 F-FDG ( 18 F-FDG PET) is increasingly used in the definition of target volumes
for radiotherapy, especially in patients with non–small cell lung cancer (NSCLC). In this …

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised …

U Nestle, T Schimek-Jasch, S Kremp… - The Lancet …, 2020 - thelancet.com
Background With increasingly precise radiotherapy and advanced medical imaging, the
concept of radiotherapy target volume planning might be redefined with the aim of improving …

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 …

…, D Lerouge, D Antoni, B Lamezec, U Nestle… - The Lancet …, 2022 - thelancet.com
Background In patients with non-small-cell lung cancer (NSCLC), the use of postoperative
radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis …

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis

U Nestle, K Walter, S Schmidt, N Licht, C Nieder… - International Journal of …, 1999 - Elsevier
Purpose: 18 F-deoxyglucose positron emission tomography (FDG-PET) is increasingly applied
in the staging of lung cancer (LC). This study analyzes the potential contribution of PET in …

Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211

…, MP MacManus, OR Mawlawi, U Nestle… - Medical …, 2017 - Wiley Online Library
Purpose The purpose of this educational report is to provide an overview of the present state‐of‐the‐art
PET auto‐segmentation ( PET ‐ AS ) algorithms and their respective validation, …

[HTML][HTML] Safety and efficacy of stereotactic body radiotherapy for stage I non–small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis

…, I Ernst, U Ganswindt, R Holy, U Nestle… - Journal of Thoracic …, 2013 - Elsevier
Introduction: To evaluate safety and efficacy of stereotactic body radiotherapy (SBRT) for
stage I non–small-cell lung cancer (NSCLC) in a patterns-of-care and patterns-of-outcome …

European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung …

…, C Faivre-Finn, D Moeller, U Nestle… - Radiotherapy and …, 2017 - Elsevier
Purpose To update literature-based recommendations for techniques used in high-precision
thoracic radiotherapy for lung cancer, in both routine practice and clinical trials. Methods A …